CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0005 (-4.35%)
At close: Jul 17, 2026

CERO Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.861.663.331.60.481.1
Cash & Short-Term Investments
0.861.663.331.60.481.1
Cash Growth
-83.52%-50.03%107.78%236.49%-56.68%-
Other Current Assets
0.721.070.390.370.230.26
Total Current Assets
1.572.733.711.9742.371.36
Net Property, Plant & Equipment
0.630.911.993.16--
Other Long-Term Assets
--0.5-41.67178.72
Total Assets
2.213.646.215.1342.37180.08
Accounts Payable
7.697.584.511.671.650.01
Accrued Expenses
0.70.71.910.140.60.08
Short-Term Debt
---0.60.65-
Current Portion of Leases
0.460.70.880.77--
Other Current Liabilities
2.480.110.110.3227.850
Total Current Liabilities
11.339.097.43.5130.750.1
Long-Term Debt
0.14---9.159.15
Long-Term Leases
--0.71.58--
Total Long-Term Liabilities
0.14-0.71.589.159.15
Total Liabilities
11.469.098.15.0839.99.25
Preferred Stock
7.227.263.1880.13--
Common Stock
000000
Additional Paid-in Capital
80.2478.1365.851.03--
Retained Earnings
-96.72-90.84-70.92-43.09-10.76-7.67
Total Common Shareholders' Equity
-9.26-5.45-1.89-42.06-10.76-7.67
Minority Interest
---4.0813.22178.5
Shareholders' Equity
-9.26-5.45-1.89-37.982.47170.83
Total Liabilities & Equity
2.213.646.215.1342.37180.08
Total Debt
0.60.71.582.949.89.15
Net Cash (Debt)
0.260.961.75-1.34-9.32-8.05
Net Cash Growth
-73.10%-45.01%----
Net Cash Per Share
0.020.2360.46-4600.99-837.83-2938.48
Book Value
-9.26-5.45-1.89-42.06-10.76-7.67
Book Value Per Share
-0.81-1.29-65.39-144083.00-966.43-2799.22
Tangible Book Value
-9.26-5.45-1.89-42.06-10.76-7.67
Tangible Book Value Per Share
-0.81-1.29-65.39-144083.00-966.43-2799.22